GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")
GRACE exists to improve the lives of women diagnosed with gynaecological cancers. It aims to improve the detection and treatment of these cancers through raising awareness, funding research, pioneering medical equipment and provision of emotional support to women. The charity supports the delivery of clinical excellence and high-quality care within the South East.
Financial health, per its FY2025 accounts
The accounts state that the charity achieved its first surplus since the pandemic, with a net movement in funds of £14,943 for the year ended 31 March 2025. Per the trustees' report, unrestricted net assets of £89,468 provide sufficient funds to cover running costs for at least fifteen months, although this falls short of the stated eighteen-month reserves target. The financial position is described as stable and improved compared to the previous year's deficit.
What the accounts disclose
“Income from charitable activities: Fund raising 3 70,799”
“This falls short of Grace’s revised reserves target of eighteen months.”
Register events
- Received assets from another charity (31/12/2021)
Trustees
- SIMON BUTLER-MANUELchair
- Dr Agnieszka Michael
- Edward Christian John Wells
- Lynn Elizabeth Vellin
- RICHARD WILLACY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £92k | £78k |
| 31/03/2024 | £79k | £83k |
| 31/03/2023 | £110k | £98k |
| 31/03/2022 | £73k | £138k |
| 31/03/2021 | £47k | £107k |
Common questions
Is GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") financially healthy?
Per its FY2025 accounts: The accounts state that the charity achieved its first surplus since the pandemic, with a net movement in funds of £14,943 for the year ended 31 March 2025. Per the trustees' report, unrestricted net assets of £89,468 provide sufficient funds to cover running costs for at least fifteen months, although this falls short of the stated eighteen-month reserves target. The financial position is described as stable and improved compared to the previous year's deficit. Its FY2025 accounts were independently examined.